GlassScriptPhysician profile
Benjamin T Jeffcoat
NPI 1679792295
$1,674.73
in general payments reported to CMS, 2019-2025
17 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $74.93 · 2021: $229 · 2022: $107 · 2023: $297 · 2024: $80.37 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $412.16 | 2021-2025 | Dupixent |
| Intersect Ent, INC. | $281.00 | 2019-2022 | |
| Optinose US, INC. | $210.34 | 2019 | |
| Glaxosmithkline, LLC. | $210.00 | 2021-2025 | Nucala |
| Acclarent, INC | $117.55 | 2023 | Trudi Nav Cable |
| Medtronic USA, INC. | $107.96 | 2019 | |
| Stryker Corporation | $101.53 | 2019-2022 | |
| Integra Lifesciences Corporation | $58.05 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Merck Sharp & Dohme LLC | $36.66 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $23.32 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.62 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.67 | 2025 | |
| Allergan, INC. | $18.37 | 2019 | |
| Medtronic, INC. | $15.42 | 2021 | |
| Olympus America INC. | $15.39 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $12.98 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Jeffcoat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.